Verastem, Inc. (VSTM)
6.58
+0.24
(+3.79%)
USD |
NASDAQ |
Apr 17, 16:00
6.575
0.00 (0.00%)
After-Hours: 20:00
Verastem Research and Development Expense (Quarterly) : 31.68M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Johnson & Johnson | 3.527B |
| Merck & Co., Inc. | 2.499B |
| Altimmune, Inc. | 18.38M |
| Ocugen, Inc. | 10.67M |
| Xilio Therapeutics, Inc. | 18.12M |